Feedback / Questions
tilavonemab (ABBV-8E12) - AbbVie
http://www.ncbi.nlm.nih.gov/pubmed/39462124
Elham Yousefi; Franz König; Franziska Hopfner; Günter Höglinger; Martin Posch; Mats O Karlsson; Mohamed Gewily; Robin Ristl; Sonja Zehetmayer
Oct 27, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next